Breakthrough Cooperation of Legend Capital’s Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
HONG KONG, Jun 15, 2022 – […]
Legend Capital Portfolio: Japan’s NO.1 VTuber Operator ANYCOLOR Lists on the Tokyo Stock Exchange
HONG KONG, Jun 9, 2022 – […]
Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully
HONG KONG, Apr 7, 2022 – […]
Legend Holdings (3396.HK) Announced 2021 Annual Results
HONG KONG, Apr 1, 2022 – […]
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital
HONG KONG, Mar 3, 2022 – […]
Legend Capital leads ForQaly Medical’s Series B financing
HONG KONG, Oct 8, 2021 – […]
Legend Capital is reaping the rewards in its logistics and supply chain investment
HONG KONG, Sep 27, 2021 – […]
Legend Capital Led a New Round of Investment of Etana
HONG KONG, Sep 14, 2021 – […]
Legend Capital enjoys 4 MedTech IPOs in 1H2021, focusing on long-term and innovation investment
HONG KONG, Sep 10, 2021 – […]
Legend Capital invests in Series A funding round of BioMap, a biological computing platform
HONG KONG, Jul 30, 2021 – […]
Dook Media, a Full Copyright Operator, invested by Legend Capital Successfully Listed on the China GEM
HONG KONG, Jul 19, 2021 – […]
Legend Holdings Announces 2020 Annual Results, Revenue and Net Profit up by 7%
HONG KONG, Apr 1, 2021 – […]
Legend Holdings 2020 Revenue and Net Profit Attributable to Equity Holders of the Company Both Rose by 7%
HONG KONG, Mar 31, 2021 – […]